Lethality of PAK3 and SGK2 shRNAs to Human Papillomavirus Positive Cervical Cancer Cells Is Independent of PAK3 and SGK2 Knockdown
Nannan Zhou(Chinese Academy of Sciences), Fiona McPhee(Bristol-Myers Squibb (United States))
Cited by 9
Related Papers
All‐oral 12‐week treatment with daclatasvir plus sofosbuvir in patients with hepatitis C virus genotype 3 infection: ALLY‐3 phase III study
|Hepatology|2015|689
<i>In Vivo</i> Patterns of Resistance to the HIV Attachment Inhibitor BMS-488043
|Antimicrobial Agents and Chemotherapy|2010|54